NIH-funded research Fellowship grant

Understanding how tau protein changes affect Alzheimer's and related dementias

Official title: Investigating physiological pathways modulating tau homeostasis: potential implications for Alzheimer's Disease and Related Dementia

Funded at Johns Hopkins University · NIH-10899143 · Data updated 2026-11-12

This study is looking at how changes in certain body processes affect tau protein levels, which are important for understanding Alzheimer's disease, and it hopes to find new ways to help treat patients with Alzheimer's and similar conditions.

More Alzheimer's Disease research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJuly 1, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$48,974
NIH project number1F31AG087599-01
Project IDNIH-10899143 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related dementias, as well as those with amyotrophic lateral sclerosis (ALS).

Less likely to help

Patients with non-neurodegenerative conditions or those without any form of dementia are unlikely to benefit from this research.

What this research studies

This research investigates the physiological pathways that regulate tau protein levels, which are crucial in the development of Alzheimer's disease and related dementias. By examining how disruptions in these pathways lead to tau abnormalities, the study aims to uncover the underlying mechanisms contributing to neurodegeneration. The research utilizes biochemical and proteomic analyses of patient samples to identify potential therapeutic targets. Patients may benefit from insights gained that could lead to new treatment strategies for Alzheimer's and related conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for Alzheimer's disease and related dementias, potentially improving patient outcomes.

How similar studies have gone: Previous research has shown promising results in understanding tau protein dynamics in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Jimenez-Ornelas, Consuelo — Johns Hopkins University
  • Study coordinator: Jimenez-Ornelas, Consuelo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.